Nanoparticle-Directed Antioxidant Therapy Can Ameliorate Disease Progression in a Novel, Diet-Inducible Model of Coronary Artery Disease
Arteriosclerosis, Thrombosis, and Vascular Biology · 2024
DOI: 10.1161/atvbaha.124.321030 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2024. Verfasst von Shi Su und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Institute (S.S., Z.C., Q.K., P.M.K.), Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA. Hauptthemen laut MEDLINE: Disease Models, Animal, Coronary Artery Disease, Nanoparticles, Mice, Knockout. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIAID NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Oxidative stress plays a crucial role in the pathogenesis of coronary artery disease. In cardiovascular research using murine models, the generation and maintenance of models with robust coronary arterial atherosclerosis has been challenging. METHODS: We characterized a new mouse model in which the last 3 amino acids of the carboxyl terminus of the HDL (high-density lipoprotein) receptor (SR-B1 [scavenger receptor, class B, type 1]) were deleted in a low-density lipoprotein receptor knockout (LDLR −/− ) mouse model (SR-B1ΔCT/LDLR −/− ) fed an atherogenic diet. We also tested the therapeutic effects of an oxidative stress-targeted nanoparticle in atherogenic diet–fed SR-B1ΔCT/LDLR −/− mice. RESULTS: The SR-B1ΔCT/LDLR −/− mice fed an atherogenic diet had occlusive coronary artery atherosclerosis, impaired cardiac function, and a dramatically lower survival rate, compared with LDLR −/− mice fed the same diet. As SR-B1ΔCT/LDLR −/− mice do not exhibit female infertility or low pup yield, they are far easier and less costly to use than the previously described SR-B1–based models of coronary artery disease. We found that treatment with the targeted nanoparticles improved the cardiac functions and corrected hematologic abnormalities caused by the atherogenic diet in SR-B1ΔCT/LDLR −/− mice but did not alter the distinctive plasma lipid levels. CONCLUSIONS: The SR-B1ΔCT/LDLR −/− mice developed diet-inducible, fatal atherosclerotic coronary artery disease, which could be ameliorated by targeted nanoparticle therapy. Our study provides new tools for the development of cardiovascular therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiovascular Institute (S.S., Z.C., Q.K., P.M.K.), Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
- Department of Pathology and Center for Vascular Biology Research (O.K.), Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
- Department of Biology, Massachusetts Institute of Technology, Cambridge (M.K.).
ORCID-Profile: Zhifen Chen, Olivier Kocher, Monty Krieger, Peter M Kang
Förderung
- NHLBI NIH HHS
- NIAID NIH HHS
- NIDDK NIH HHS
- NCATS NIH HHS
Zitieren
APA
Su, S., Chen, Z., Ke, Q., Kocher, O., Krieger, M., & Kang, P. M. (2024). Nanoparticle-Directed Antioxidant Therapy Can Ameliorate Disease Progression in a Novel, Diet-Inducible Model of Coronary Artery Disease. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.124.321030
Vancouver
Su S, Chen Z, Ke Q, Kocher O, Krieger M, Kang PM. Nanoparticle-Directed Antioxidant Therapy Can Ameliorate Disease Progression in a Novel, Diet-Inducible Model of Coronary Artery Disease. Arteriosclerosis, Thrombosis, and Vascular Biology. 2024. doi:10.1161/atvbaha.124.321030
BibTeX
@article{Su2024,
author = {Su, Shi and Chen, Zhifen and Ke, Qingen and Kocher, Olivier and Krieger, Monty and Kang, Peter M},
title = {Nanoparticle-Directed Antioxidant Therapy Can Ameliorate Disease Progression in a Novel, Diet-Inducible Model of Coronary Artery Disease},
journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
year = {2024},
doi = {10.1161/atvbaha.124.321030}
}
EUVIMED